Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.000.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.10% | -108.50% | 35.58% | 4.21% | -72.86% |
| Total Depreciation and Amortization | 77.27% | 26.09% | -26.92% | -27.59% | -31.25% |
| Total Amortization of Deferred Charges | -20.90% | -67.06% | -80.05% | -87.38% | -72.43% |
| Total Other Non-Cash Items | 227.65% | 78.19% | -95.43% | -205.52% | -133.96% |
| Change in Net Operating Assets | 40.67% | 132.87% | 21.34% | 12.37% | 260.49% |
| Cash from Operations | 99.52% | -17.83% | -27.04% | -2,923.94% | -52.10% |
| Capital Expenditure | 91.67% | 41.67% | 53.85% | 46.67% | 29.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.40% | -13.40% | 2.99% | 274.33% | 704.34% |
| Cash from Investing | -13.16% | -13.10% | 3.53% | 282.29% | 678.70% |
| Total Debt Issued | 92.36% | 4.33% | -43.11% | -54.80% | -58.80% |
| Total Debt Repaid | -70.81% | -5.02% | 36.81% | 49.81% | 27.15% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.32% | -8.17% | -200.43% | -20.03% | -154.62% |
| Foreign Exchange rate Adjustments | 115.79% | -60.00% | 222.22% | 125.93% | -18.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.73% | -284.80% | -490.24% | -511.29% | -320.15% |